Clinical trials recruiting in Lucerne, Switzerland

Phase breakdown

Conditions recruiting in Lucerne, Switzerland

Recruiting trials in Lucerne, Switzerland

• A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
  NCT06790693 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.
  NCT02102165 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
  NCT05939414 · Phase: Phase 3 · Ages: 18 Years to 100 Years · Sex: Male
• Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
  NCT07140172 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
  NCT04045691 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Colchicine After Electrocardioversion for Atrial Fibrillation
  NCT05890664 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  NCT06401980 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male
• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
  NCT07064473 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy
  NCT05976685 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Early Detection and IntervenTion in Heart Failure
  NCT07731490 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years and older · Sex: All (male and female)
• Extended vs. No Pelvic Lymph Node Dissection During Radical Prostatectomy. DISSECTION 2.0.
  NCT06776172 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male
• Giving Children a Voice in Paediatric Anaesthesia
  NCT07524049 · Phase: Not specified · Ages: 6 Years and older · Sex: All (male and female)
• Hypnosis and Attention in Patients With a Neurological Disease (Stroke, Traumatic Brain Injury and Multiple Sclerosis)
  NCT07256704 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Improving Functional Outcomes and Quality of Life in Patients With Rectal Cancer After Surgery With Intensified Follow-up & Surveillance
  NCT06936774 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Intelligent Vacuum Assisted Biopsy Immediately Before Surgery As an Intra- or Pre-Operative Surrogate for Patient Response to Neoadjuvant Chemotherapy for Breast Cancer
  NCT04289935 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC)
  NCT07149649 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
  NCT07037459 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female)
• Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
  NCT06765109 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• New Interactive Sensor-home-based Hand Training to Improve Dexterity
  NCT06062693 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 99 Years · Sex: All (male and female)
• Primary and Acquired Resistance to Targeted Treatment in BRAF V600E-mutated Metastatic Colorectal Cancer
  NCT07617610 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Failure
  NCT06557798 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Role of Intrapulmonary Lymph Nodes in Patients With NSCLC and Visceral Pleural Invasion
  NCT05596578 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Skin Cancer and Hyperthermia and Radiotherapy
  NCT06384053 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years and older · Sex: All (male and female)
• Swiss Paediatric Airway Cohort
  NCT03505216 · Phase: Not specified · Ages: 0 Years to 16 Years · Sex: All (male and female)
• Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
  NCT05017142 · Phase: Not specified · Ages: Up to 36 Years · Sex: All (male and female)
• Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)
  NCT07365423 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male
• The "Global Paradise System" Registry
  NCT05027685 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• The SwissPrEPared Study
  NCT03893188 · Phase: Not specified · Ages: 16 Years to 120 Years · Sex: All (male and female)
• Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerland
  NCT05819463 · Phase: Not specified · Ages: 12 Years and older · Sex: All (male and female)
• Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients
  NCT06114108 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Lucerne, Switzerland?

30 recruiting trials have at least one study site in Lucerne, Switzerland.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.